FISH Analysis of Gene Aberrations (MYC, CCND1, ERBB2, RB, and AR) in Advanced Prostatic Carcinomas Before and After Androgen Deprivation Therapy
- 1 September 2000
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 80 (9), 1455-1464
- https://doi.org/10.1038/labinvest.3780152
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expressionBritish Journal of Cancer, 1999
- Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc geneOncogene, 1999
- Cyclin D1 expression in human prostate carcinoma cell lines and primary tumorsThe Prostate, 1998
- Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1Oncogene, 1998
- Regulation of Cyclin D1 by Calpain ProteasePublished by Elsevier ,1997
- Improved technique for analysis of formalin‐fixed, paraffin‐embedded tumors by fluorescence in situ hybridizationCytometry, 1994
- Expression of the c-erbB-2 (Her-2/neu) Oncoprotein in Human Prostatic CarcinomaJournal of Urology, 1993
- In situ end‐labelling detects DNA strand breaks in apoptosis and other physiological and pathological statesThe Journal of Pathology, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical StagingJournal of Urology, 1974